IHS Chemical Week

Regions :: China

Bayer to acquire Chinese pharmaceutical company

1:55 AM MST | February 27, 2014 | Deepti Ramesh

Bayer plans to acquire Dihon Pharmaceutical Group (Kunming, China), a privately held pharmaceutical company specializing primarily in over-the-counter (OTC) and herbal traditional Chinese medicine (TCM) products. Financial details of the acquisition have not been disclosed. Dihon generated sales of €123 million ($168 million) in 2013, and it employs about 2,400 people, Bayer says. Dihon has several manufacturing sites throughout China. The acquisition is expected to close in the second half of 2014, Bayer says. “We aim to strengthen our life sciences...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa